短宫颈女性阴道用孕酮后宫颈长度缩短与≤34周和<37周早产显著相关
这项回顾性队列研究纳入197例孕18+0至23+6周宫颈长度≤25 mm的单胎妊娠,在阴道用孕酮开始后至少1周复查宫颈长度。宫颈长度缩短≥20%与≤34周早产(OR 4.11)和<37周早产(OR 3.62)关联最强,阳性似然比最高。
要点
- 阴道用孕酮后宫颈长度缩短≥20%与≤34周和<37周早产关联最强。
- 缩短≥20%预测≤34周早产的阳性似然比为2.98,<37周为2.89。
- 缩短≥10%的敏感性最高,但≥20%缩短与早产关联最强。
核心结论
- 短宫颈女性阴道用孕酮后复查超声发现宫颈长度缩短可预测≤34周和<37周早产。
- 宫颈长度缩短≥20%较≥10%或≥5 mm缩短具有最高阳性似然比和最强关联。
研究设计与样本
- 回顾性队列研究,纳入197例孕18+0至23+6周宫颈长度≤25 mm的单胎妊娠,其中无早产史178例、有早产史19例。
- 所有孕妇在阴道用孕酮开始后至少1周复查经阴道宫颈长度。
主要发现
- 总体早产率≤34周为16.8%(33/197),<37周为36.5%(72/197)。
- 宫颈缩短以百分比表示预测≤34周和<37周早产的ROC曲线下面积分别为0.703和0.608。
- 197例中60例(30.5%)观察到宫颈缩短,其中49/60(81.7%)缩短≥10%、32/60(53.3%)缩短≥20%、27/60(45.0%)缩短≥5 mm。
- 预测≤34周早产的敏感度和特异度分别为:缩短≥10%为48.5%和79.9%,≥20%为36.4%和87.8%,≥5 mm为27.3%和89.0%。
- 预测<37周早产的敏感度和特异度分别为:缩短≥10%为36.1%和81.6%,≥20%为27.8%和90.4%,≥5 mm为20.8%和90.4%。
关键数值与推荐
- 宫颈缩短≥20%预测≤34周早产的阳性似然比为2.98(95% CI,1.62-5.49),预测<37周为2.89(95% CI,1.52-5.57)。
- 宫颈缩短≥20%与≤34周早产相关(OR 4.11(95% CI,1.75-9.62)),与<37周早产相关(OR 3.62(95% CI,1.65-7.96)),对照为宫颈缩短程度较轻者。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the association between changes in cervical length (CL) after vaginal progesterone treatment and preterm delivery (PTD). METHODS: This was a retrospective cohort study that included 197 singleton pregnancies without (n = 178) and with (n = 19) a history of PTD which were found to have a short cervix (≤ 25 mm) between 18 + 0 and 23 + 6 weeks' gestation with a follow-up transvaginal CL measurement taken at least 1 week after vaginal progesterone treatment started. Receiver-operating-characteristics (ROC)-curve analysis was performed and three CL shortening patterns were evaluated: (1) ≥ 10% reduction; (2) ≥ 20% reduction; and (3) ≥ 5 mm reduction relative to the first CL measurement. The predictive performance of each CL reduction cut-off and its association with PTD ≤ 34 weeks and PTD < 37 weeks were evaluated. RESULTS: Overall, the rate of PTD ≤ 34 weeks was 16.8% (33/197) and that of PTD < 37 weeks was 36.5% (72/197). The area under the ROC curve of cervical shortening expressed in % for predicting PTD ≤ 34 weeks and PTD < 37 weeks was 0.703 and 0.608, respectively. Cervical shortening was observed in 60/197 (30.5%) patients, with 49/60 (81.7%) women showing ≥ 10% reduction, 32/60 (53.3%) ≥ 20% reduction and 27/60 (45.0%) ≥ 5 mm reduction in CL. Sensitivity and specificity for PTD ≤ 34 weeks were, respectively, 48.5% and 79.9% for ≥ 10% reduction; 36.4% and 87.8% for ≥ 20% reduction; and 27.3% and 89.0% for ≥ 5 mm reduction in CL. For PTD < 37 weeks, sensitivity and specificity were, respectively, 36.1% and 81.6% for ≥ 10% reduction; 27.8% and 90.4% for ≥ 20% reduction; and 20.8% and 90.4% for ≥ 5 mm reduction in CL. The highest positive likelihood ratios for PTD ≤ 34 and < 37 weeks were for ≥ 20% CL reduction (2.98 (95% CI, 1.62-5.49) and 2.89 (95% CI, 1.52-5.57), respectively). Despite significant differences in sensitivity among the different cut-offs for cervical shortening, favoring the ≥ 10% reduction cut-off, a reduction of ≥ 20% in CL showed the strongest association with PTD ≤ 34 weeks (odds ratio (OR), 4.11 (95% CI, 1.75-9.62)) and < 37 weeks (OR, 3.62 (95% CI, 1.65-7.96)), as compared with a less pronounced reduction in CL. CONCLUSIONS: In women with a short cervix treated with vaginal progesterone, a reduction in CL on a subsequent ultrasound scan can predict PTD ≤ 34 and < 37 weeks. A ≥ 20% reduction in CL had the highest positive likelihood ratio and strongest association with PTD ≤ 34 and < 37 weeks compared with ≥ 10% or ≥ 5 mm reduction. © 2023 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Hernandez-Andrade E, Huntley ES, Sibai B, et al. Reduction in cervical length after vaginal progesterone in women with short cervix is significantly associated with preterm delivery at ≤ 34 weeks and < 37 weeks of gestation. Ultrasound Obstet Gynecol. 2024. PMID: 37916641. doi:10.1002/uog.27527
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。